Back
Editas Medicine Stock Price Chart
Sponsored
EDIT
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
EDIT
Editas Medicine
Last Price:
2.44
Seasonality Move:
13.73%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight buying pressure.
Editas Medicine Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.58 | Sell |
20-day SMA: | 2.89 | Sell |
50-day SMA: | 3.21 | Sell |
200-day SMA: | 5.21 | Sell |
8-day EMA: | 2.58 | Sell |
20-day EMA: | 2.83 | Sell |
50-day EMA: | 3.21 | Sell |
200-day EMA: | 4.98 | Sell |
Editas Medicine Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 33.29 | Sell |
Chaikin Money Flow: | 166015 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.64 - 3.32) | Sell |
Bollinger Bands (100): | (2.97 - 4.75) | Sell |
Editas Medicine Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
- Editas Medicine share price is 2.44 while EDIT 8-day simple moving average is 2.58, which is a Sell signal.
- The stock price of EDIT is 2.44 while Editas Medicine 20-day SMA is 2.89, which makes it a Sell.
- Editas Medicine 50-day simple moving average is 3.21 while EDIT share price is 2.44, making it a Sell technically.
- EDIT stock price is 2.44 and Editas Medicine 200-day simple moving average is 5.21, creating a Sell signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
40
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a Sell
The current Editas Medicine [EDIT] share price is $2.44. The Score for EDIT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine Stock Info
Market Cap:
201.42M
Price in USD:
2.44
Share Volume:
2.27M
Editas Medicine 52-Week Range
52-Week High:
11.69
52-Week Low:
2.30
Sell
40
Editas Medicine (EDIT)
is a Sell
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?
The Editas Medicine stock price is 2.44 USD today. -
Will EDIT stock go up or go down?
Editas Medicine> share price is forecast to RISE/FALL based on technical indicators -
Is Editas Medicine overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is overvalued.
Is Editas Medicine Stock a Buy?
- Editas Medicine share price is 2.44 while EDIT 8-day exponential moving average is 2.58, which is a Sell signal.
- The stock price of EDIT is 2.44 while Editas Medicine 20-day EMA is 2.83, which makes it a Sell.
- Editas Medicine 50-day exponential moving average is 3.21 while EDIT share price is 2.44, making it a Sell technically.
- EDIT stock price is 2.44 and Editas Medicine 200-day simple moving average is 4.98, creating a Sell signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.23 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
- EDIT Moving Average Covergence Divergence (MACD) indicator is -0.23, suggesting Editas Medicine is a Sell
- Editas Medicine Relative Strength Index (RSI) is 33.29, which suggest Editas Medicine is oversold
- The Bollinger Bands (25) for Editas Medicine is (2.64 - 3.32), which suggest Editas Medicine is a Sell
- The Bollinger Bands (100) for Editas Medicine is (2.97 - 4.75), which suggest Editas Medicine is a Sell
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.